Cite
HARVARD Citation
Selinger, C. et al. (2021). Acceptability of a 'treat to target' approach in inflammatory bowel disease to patients in clinical remission. Frontline gastroenterology. 12 (1), pp. 30-38. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Selinger, C. et al. (2021). Acceptability of a 'treat to target' approach in inflammatory bowel disease to patients in clinical remission. Frontline gastroenterology. 12 (1), pp. 30-38. [Online].